Introduction: Mutational analysis is commonly used to support the diagnosis and management of haemophilia. This has allowed for the generation of large mutation databases which provide unparalleled insight into genotypephenotype relationships. Haemophilia is associated with inversions, deletions, insertions, nonsense and missense mutations. Both synonymous and non-synonymous mutations influence the base pairing of messenger RNA (mRNA), which can alter mRNA structure, cellular half-life and ribosome processivity/elongation. However, the role of mRNA structure in determining the pathogenicity of point mutations in haemophilia has not been evaluated. Aim: To evaluate mRNA thermodynamic stability and associated RNA prediction software as a means to distinguish between neutral and disease-associated mutations in haemophilia. Methods: Five mRNA structure prediction software programs were used to assess the thermodynamic stability of mRNA fragments carrying neutral vs. diseaseassociated and synonymous vs. non-synonymous point mutations in F8, F9 and a third X-linked gene, DMD (dystrophin). Results: In F8 and DMD, disease-associated mutations tend to occur in more structurally stable mRNA regions, represented by lower MFE (minimum free energy) levels. In comparing multiple software packages for mRNA structure prediction, a 101-151 nucleotide fragment length appears to be a feasible range for structuring future studies. Conclusion: mRNA thermodynamic stability is one predictive characteristic, which when combined with other RNA and protein features, may offer significant insight when screening sequencing data for novel diseaseassociated mutations. Our results also suggest potential utility in evaluating the mRNA thermodynamic stability profile of a gene when determining the viability of interchanging codons for biological and therapeutic applications.
Introduction
With the molecular underpinnings of haemophilia defined for over three decades, mutational analysis is now commonly performed to support diagnosis and management. In the majority of cases, a causative genetic insult is identified, however, the assessment of novel and uncharacterized sequence variants remains challenging. The influence of mRNA structure in determining the pathogenicity of synonymous and non-synonymous point mutations remains incompletely evaluated. The curated collections of diseaseassociated and neutral point mutations in haemophilia provide the requisite information to reliably evaluate such genotype-phenotype questions. In our previous study [1, 2] , mRNA structure/stability was identified as the second most significant variable, among more than 40 assessed RNA and protein characteristics, for distinguishing disease-causing and neutral point mutations in F8 and F9. We previously showed that other variables such as primary sequence/structural conservation scores, as well as changes to charge, polarity, phosphorylation potential and GC content are informative in differentiating between neutral and pathogenic mutations.
Even slight alterations to mRNA folding can alter biological activity [3] [4] [5] . Altered stability of mRNA can lead to protein overproduction or underproduction, which has strong implications for the manifestation of human disease [6, 7] . There is now evidence that altering the native structure of mRNA via synonymous mutations may also impact the kinetics of translation and cotranslational protein folding. The most common mutation underlying cystic fibrosis, ΔF508 in the CFTR gene, includes not only the deletion itself but also a synonymous nucleotide substitution in the adjacent isoleucine codon. This synonymous mutation alters the CFTR mRNA structure and contributes significantly to the misfolding of the protein [8] . More globally, others have found that mRNA structure has a prominent influence on ribosome elongation rate. Experimental evidence indicates that mRNA structure can impact the folding of a protein, specifically that mRNA secondary structures can serve as elongation brakes to control the speed and hence the fidelity of protein translation [9] .
Because RNA structure and stability are onerous to assess using in vitro methods, in silico tools that render possible RNA conformations based solely on the nucleotide sequence provide a convenient medium for studying RNA structure. Computer algorithms, such as those used in MFOLD [10] , KINEFOLD [11] and VIEN-NARNA [12] have become adept at making large quantities of thermodynamic computations to predict plausible structures. Each of these software programs computes an mRNA thermodynamic stability value in the form of minimum free energy (MFE), a thermodynamic energy measurement that is based on intramolecular stacking and hydrogen bond interactions. MFE determination involves variables such as the system's temperature, entropy, enthalpy and ionic conditions and is representative of a variety of contributing substructural elements, such as loops, hairpins and a variety of turns [13] . A lower MFE value is representative of a more stable structure [14, 15] . For a given fragment length, the nucleotide sequence solely determines MFE computation. Longer fragments tend to generate more stacking and hydrogen bond interactions and therefore more stable structures. However, large coding mRNA molecules are often analysed in arbitrarily determined segments, and these fragment lengths are not standardized among existing software programs.
In this study, we constructed databases of diseaseassociated and neutral point mutations in the coding region of three genes: the factor VIII gene (F8), the factor IX gene (F9) and a third X-linked gene, dystrophin (DMD), associated with Duchenne/Becker muscular dystrophy. This study uses these clinically relevant data sets with five highly utilized RNA prediction software (KINEFOLD, MFOLD v3.6, NUPACK v3.0.4, REMURNA and VIENNARNA v2.1.7) to evaluate RNA thermodynamic stability in regions with synonymous and non-synonymous mutations. We observed significant differences between mRNA thermodynamic stability in regions with disease-associated vs. neutral mutations and synonymous mutations vs. non-synonymous mutations. The biological significance of these observations and possible application to recombinant protein design are discussed. Lastly, we evaluated 10 unique mRNA fragments sizes (25, 51, 75, 101, 125, 151, 175, 201, 225 and 251 nucleotides (nt)) and demonstrated that each prediction software program has a unique regression pattern. A range of preferable fragment sizes for future in silico evaluation of mRNA structure is suggested.
Methods

Database construction
Disease-associated single nucleotide mutations for coagulation factor VIII and factor IX, coded by F8 and F9 genes, respectively, were obtained from updated versions of databases previously described Hamasaki-Katagiri et al. [1] , originally extracted from the Center for Disease Control and Prevention's (CDC) Haemophilia A and B Mutation Project (CHAMP/CHBMP) databases (http://www.cdc.gov/ ncbddd/hemophilia/champs.html). Single nucleotide mutations for dystrophin, coded by the DMD gene (Dp427 m isoform transcript, full length muscular type) associated with Duchenne and Becker muscular dystrophy, were extracted from NCBI dbSNP (NM_004006.2). Neutral single nucleotide mutations in the F8 and F9 genes were extracted from NCBI dbSNP (NM_000132.3 and NM_000133.3).
Only single unique nucleotide mutations in the open reading frame (ORF) were included in the database; multiple SNPs in one allele, insertions/deletions, frameshift, nonsense mutations and mutations which lack comprehensive genetic or clinical data were excluded. Data from mutations in the 5 0 and 3 0 UTR region and non-coding regions were also excluded from the analysis because regions such as the UTR play different roles in translation, and as a result, it is difficult to establish a direct correlation between the point mutation and RNA thermodynamic stability. Other mutation databases were not considered because most data sets do not explicitly categorize mutations. Primary mutation information, such as the position of mutation and nucleotide substitution, mutation type, and functional or clinical information, were obtained through NCBI Genbank and UniProt with entry numbers of P00451, P00740 and P11532 for F8, F9 and DMD respectively. Mutations in the F8 and F9 genes of all three severities (mild, moderate and severe) were collectively considered 'diseaseassociated' mutations. 2+ and at 37°C. The only exception was KINEFOLD, for which, to ensure consistency and expediency, the random seed was set to 999, and the folding time to 1000 ms. KINEFOLD's default setting utilizes cotranscriptional folding, but it also provides the option of performing a renaturation fold with 1 M NaCl and cooling from 99°C to 37°C (only default settings were used in this study). Summary of these five software programs are listed in Table 1 . The three algorithms in MFOLD, NU-PACK and VIENNARNA all utilize a similar dynamic programming paradigm to enumerate a family of possible RNA structures and then select the most likely structure based on minimizing the predicted structure's free energy. However, this paradigm is forced to ignore all pseudoknotted RNA structures because their inclusion likely results in an exponential increase in both the runtime and storage space. KINEFOLD allows for the inclusion of certain classes of pseudoknots by performing a stochastic simulation of the kinetic folding process. VIENNARNA has an option to consider pseudoknots (RNAPKplex component of the VIENNARNA package). However, this option was not used in this study because the program is generally used as an extension tool for evaluating the accessibility of regions for forming pseudoknotted structures. REMURNA operates differently from the other algorithms as it was created as an ensemble-based program to compare between structural ensembles which include unique point mutations. In addition to MFE estimation, REMURNA also outputs a corresponding enthalpy value.
MFE prediction
For each mutation, MFE values were computed for the associated RNA conformations at 10 different sequence lengths: 25, 51, 75, 101, 125, 151, 175, 201, 225 and 251 nt. For each mutation site and sequence length, a subsequence of that length, centred at that mutation site, was extracted. If the mutation site was too close to the head or tail of the mRNA sequence for the subsequence to be properly centred, it was excluded. Each RNA conformation tool was run for both the wild type and mutant variants of the subsequence (these variants differed by only a single nucleotide), and ΔMFE was then calculated as MFE mutant À MFE wild type . The raw MFE values, outputted by the software programs, were used for all subsequent analysis. Average MFE values for each assessed nucleotide fragment lengths were computed as an average of the wild type MFE throughout the coding region (excluding sequences at the start of the gene sequence due to length restrictions). Average arbitrarily chosen for analysis on the effect of mutation type and disease association on RNA thermodynamic stability.
Data processing, visualization and analysis
All data processing was performed using Excel and Python, and all data analysis and data visualization was performed using R and the ggplot2 package. A Python program was written to read in a Figure S1 . The comparison of average mRNA MFE levels based on mutation type of the F8 gene across all five software programs is shown in Figure S3 . Figure S2 . The comparison of average mRNA MFE levels based on mutation type of F8. Corresponding plots for F9 and DMD are shown in Figure S2 . The comparison of average mRNA MFE levels based on mutation type of the F8 gene across all five software programs is shown in Figure S4 .
dots indicate outliers. Statistical significance of MFE in the region encompassing each mutation type or effect was compared using a two-sample t-test. In F8, this statistical test was performed for synonymous vs. non-synonymous and disease-associated vs. neutral mutations, both with and without the middle domain (amino acid #760-1667). The mutation distribution in F8 was generated with both disease-associated and neutral mutations at a fragment length of 151 nt. A smoothed baseline MFE in Fig. 1c was generated by averaging the WT MFE of a 56-nt window along the open reading frame.
Fitted linear regression
For each protein, we performed a multivariate linear regression of the form:
where I is the indicator function and b 0 is the MFE intercept. All other b variables within the linear regression equation correspond to the specific intercept value for each software. The model was fitted on points where the length >25 because for short sequence lengths, the trend in the predicted MFEs becomes non-linear. For further analysis, we calculated the slope and intercept for each mutation sequence in each data set with fragment length as the x variable and MFE as the y variable. The software algorithms were treated as sources of variation similar to treatments, and the blocks were the mutations. A randomized block ANOVA was used to compare the average slope among the five prediction methods, and then separately, the same analysis was performed for the intercept.
Approximating intersoftware conversion factors
In approximating the intersoftware conversion factors, the distance between the software's MFE values at a particular fragment length was computed as:
where a indicates the slope, and b represents the intercept value. This MFE difference corresponds to the conversion factor that must be added to convert from Software 1 to Software 2. The estimated error of this factor was determined by:
Correlation plots (by software)
Pearson correlation coefficients were calculated for the average predicted MFE values for each of the 10 sequence lengths for both the wild type and mutant sequences. A correlation score was predicted based on comparing two vectors, each with MFE values predicted by one of the five different software programs. These vectors were then used to generate the Pearson correlation coefficients. All 5 software programs and 10 different fragment lengths were assessed and plotted in a grid chart using R.
Results
Comparison of disease-associated vs. neutral mutations
The correlation between disease-associated mutations and MFE levels of mRNA fragments centred on mutation sites were analysed using data sets of point mutation in the F8, F9 and DMD genes. The MFE values for wild type F8 mRNA in the region encompassing the mutation site, predicted by REMURNA, is shown in Fig. 1a . The MFE values of wild type mRNA fragment regions longer than 25 nt showed a statistically significant difference between disease-associated and neutral mutation sites (P < 10 À6~1 0
À11
). The significance is greater when the fragment size is increased. For all assessed fragment sizes, disease-associated mutations were observed in mRNA regions with a lower MFE compared with mRNA regions containing neutral mutations. The correlation between mutation effect and the MFE value is apparent from the regression profiles for F8 and DMD genes (dashed lines in Fig. 1 and Figure S1b ). We observed a statistically significant difference between the regression profiles of disease-associated vs. neutral mutations for F8 (P < 2 9 10 À16 ) and DMD (P = 0.0297). For F9, the MFE values are virtually identical between disease-associated and neutral mutations, suggesting a possible gene-specific relationship between MFE and mutation pathogenicity ( Figure S1a ). As one way to evaluate this possibility, we performed an additional analysis of neutral and disease-associated F9 mutations using KINEFOLD, which employs cotranscriptional folding of mRNA into its algorithm. We observed no significant correlation between MFE and pathogenicity.
Factor VIII is known to have a unique large central region of the protein, encompassing the B-domain, which is cleaved out upon its activation. This region is considered to be dispensable for its function, and a variety of B-domain-deleted factor VIII recombinant proteins exist as therapeutic drugs. Most likely, this contributes to a decreased number of entries of disease-associated mutations and a higher proportion of neutral mutations in this region as evident in Fig. 1c . In comparing the MFE of disease-associated mutations vs. neutral mutations with the local baseline subtracted, disease-associated mutations are distributed at lower MFE values than neutral mutations (P = 0.0143). We also performed the same analyses but with all mutations in the central region excluded, to account for the potential selection bias in F8 sequencing data. This similarly showed that diseaseassociated mutations tend to occur in mRNA regions with lower MFE values relative to the baseline MFE, albeit with a lower defined value of statistical significance (P = 0.00279; Fig. 1b) . It should be noted that for both disease-associated and neutral mutations, the DMFE between the wild type and mutant sequence is close to 0; thus, the change in MFE resulting from the presence of the mutation does not predict pathogenicity but rather the MFE inherent to the location of the mutation (Figures 3c, S3c and S4c). We also assessed whether the mRNA region encoding for more highly conserved/functionally significant amino acid residues tend to have low MFE values relative to mRNA encoding lowly conserved residues, which could potentially underlie the direct relationship between MFE and pathogenicity. However, the correlation coefficients between amino acid/structural conservation score and MFE (as calculated by REMURNA) were low (0.14, 0.13 and 0.15 for 101, 125 and 151 nt respectively), suggesting other mechanisms for the relationship between MFE and pathogenicity in F8 ( Figure S7 ).
Comparison of synonymous vs. non-synonymous mutations
The MFE levels of mRNA fragments surrounding mutation sites were next compared between synonymous and non-synonymous mutations found in the F8, F9 and DMD genes data sets. MFE values of F8 mRNA in the region encompassing the mutation site, predicted by REMURNA are shown in Fig. 2a .
The MFE values of wild type mRNA fragment regions longer than 25 nt show a statistically significant difference between synonymous mutations and non-synonymous mutations (P < 0.09~10
À4
). The regression profile for the F8 gene shows a significant correlation with a P-value of 1.68 9 10
À10
. For F8 and DMD, across all fragment sizes, synonymous mutations were observed in mRNA regions with a higher MFE compared to regions where non-synonymous mutations are observed. The average MFE difference between wild type mRNA fragments and mutant containing fragments is close to 0, further indicating that the mutation, regardless of classification, does not influence the mRNA thermodynamic stability in a consistent manner. Unique regression profiles are still seen between synonymous and nonsynonymous mutations when excluding mutations in the middle region of FVIII, albeit with lower statistical significance than the full data set (P = 0.0223; Fig. 2b) .
It should be noted that a majority of documented disease-associated mutations are non-synonymous mutations. As a result, the observed differences in local mRNA MFE between synonymous and nonsynonymous mutations may be heavily influenced by their status as disease-associated or neutral mutations. To assess mRNA thermodynamic stability in regions with synonymous vs. non-synonymous mutations in a less biased manner, we performed a separate analysis using only neutral mutations in F8. In this analysis, 40 synonymous neutral mutations were compared against 62 neutral non-synonymous mutations. Despite the smaller size of this data set, when comparing the MFE around the neutral synonymous mutations vs. neutral non-synonymous mutations, synonymous mutations show a tendency to be located in mRNA regions with lower MFE values than non-synonymous mutations only when using fragment sizes of 101, 125 or 151 (P = 0.00976, 0.00633 and 0.0291 respectively); however, there are no significant differences when using shorter or longer fragment lengths. Moreover, when compared to the baseline MFE values, there are no significant differences between neutral synonymous and nonsynonymous mutations (P = 0.0863). This implies that there is no propensity for synonymous and nonsynonymous mutations to occupy stable or unstable regions of mRNA; instead, these tendencies are driven by their pathogenic status. A similar evaluation of F9 and DMD could not be performed due to the small number of synonymous mutations within these data sets. The small number of disease-associated synonymous mutations precludes the ability to make a statistically significant analysis of MFE values between neutral and disease-causing synonymous mutations.
MFE patterns across fragment lengths
The five prediction tools used here are KINEFOLD, MFOLD v3.6, NUPACK v3.0.4, REMURNA and the RNAfold program in VIENNARNA v2.1.7, the characteristics of which are defined in Table 1 of the Methods section. Figure 3 shows the average MFE values of mRNA at all mutation sites within our databases using 10 different mRNA fragment sizes, ranging from 25 to 251 nt, predicted by five different prediction tools. The mRNA sequences for the F8, F9 and DMD genes, including both disease-associated (n = 1032, 134 and 120 for F8, F9 and DMD respectively) and neutral mutations (n = 102, 25 and 28 for F8, F9 and DMD respectively), are constructed so that the mutation site is centred within the fragment length. The five prediction tools show a distinct and consistent trend in their patterns across the various RNA fragment sizes. KINEFOLD and MFOLD have the lowest MFE values while REMURNA has the highest MFE values (Fig. 3a, b) . As the length of the mRNA fragments increases, the MFE values decrease at a linear rate. As observed in the previous sections on the association of MFE with disease or synonymous mutations, the average MFE of the mRNA fragments of the wild type (Fig. 3a) and the mutant (Fig. 3b) around all the mutation sites are nearly identical, leading to average ΔMFE (MFE mutant À MFE wild type ) values of zero across the various mRNA fragment sizes (Fig. 3c) . Similar trends are observed in the analysis using single nucleotide mutations of the F9 and DMD genes ( Figures S5 and S6 ).
Establishing correlations among prediction tools
Plotting the average MFE values against mRNA fragment size shows clear linearity, where the P-values for all plots are less than 10 À19 , and all R 2 values are greater than 0.84 (Fig. 3d) . However, each software program exhibits unique slope and y-intercept values (Table 2) .
In all three genes, the average slope across the software programs increases from the most negative slope to the least negative slope in the following prediction tool order: MFOLD, KINEFOLD, VIENNARNA, NUPACK and REMURNA. Despite the specific differences in the slope and intercept for each prediction tool, these software programs correlate strongly to each other for F8, F9 and DMD. Figure 4 shows that MFOLD and VIENNARNA, which uses an algorithm modified from that of MFOLD, are highly correlated; that is, the Pearson correlation factor is >0.8. NUPACK and REMURNA also show a similarly high correlation. These results demonstrate a strong intersoftware correlation in which the MFE levels from different methods deviate by only a small factor. In both the F8 and DMD genes, the Pearson correlation is greater than 0.8 among all software programs. F9 shows slightly lower correlations among the software programs, particularly between KINEFOLD and the other four programs. However, the correlation is nonetheless considerably high, with a Pearson correlation greater than 0.7 across all assessed wild type and mutant fragment lengths.
For analysing the statistical relationships in data sets generated by different software tools, the calculated linear regression statistics for each software program and gene can be effectively used to establish conversion factors between the software programs. For a given fragment length, the conversion from the predicted MFE value of software 1 to software 2 requires adding the MFE difference between the two software programs. This conversion factor must incorporate both the difference between slopes and the intercepts of the two software programs, as shown by the equations in the Methods section. 
Discussion
The ability for point mutations to impact protein functions outside the context of amino acid substitutions is not commonly considered in disease association studies [16, 17] . However, any mutation can alter characteristics such as splice sites, miRNA binding, codon usage and translational/folding kinetics of a protein. Both synonymous and non-synonymous mutations may also impact mRNA structure and stability [18, 19] . The primary purpose of this study was to facilitate an understanding of mRNA thermodynamic stability in regions encompassing disease-associated vs. neutral and synonymous vs. non-synonymous mutations relevant to haemophilia. Our analysis of single nucleotide mutations found in the F8 gene and in the DMD gene revealed that disease-associated mutations tend to occur in regions where the mRNA MFE is lower than regions accommodating neutral mutations. This observation can be made despite the unequal distribution of reported disease-associated and neutral mutations, and was further confirmed after accounting for data collection bias. Such a trend was observed in our previous analysis of F8 mutations in which a more limited interrogation of mRNA characteristics was performed [1] . Further analysis using only neutral mutations also indicated that non-synonymous mutations are highly associated with disease when they occur in regions where the mRNA MFE is lower than average of neighbouring wild type MFE values (baseline). This indicates that mutations occurring in regions where the mRNA structure is more thermodynamically stable tend to be more deleterious, possibly contributing to altered expression, secretion and/or functional levels of the protein. It is to be emphasized that mutations could be deleterious even if the MFE value is not itself changed, depending on local MFE environment within the native mRNA molecule. Other factors such as the speed of elongation or binding of regulatory elements can also promote disease incidence. It cannot be excluded that such mRNA fragments may harbour important regulatory elements that, for example, may serve to recruit various regulatory proteins [20, 21] . With regard to the effects of the mutation on protein function, it is notable that both F8 and DMD code for non-catalytic proteins, which may indicate that these single nucleotide changes affect the interaction with other cellular components.
Factor replacement is the mainstay of haemophilia management. Today's recombinant versions of Factor VIII and Factor IX are of increasingly sophisticated design, which can involve the selective incorporation of synonymous and non-synonymous mutations into the coding sequence with the aim of prolonged halflife or increased protein expression yield. In the development of recombinant protein therapeutics, there is a question as to whether such mutations and interchanged synonymous codons within the coding sequence could meaningfully alter protein function and structure. All biological therapeutics undergo significant protein characterization and safety assessment prior to admission into clinical studies. However, product development is occasionally terminated prior to or after the initiation of clinical studies due to unexpected complications, which may include unforeseen effects of nucleotide substitutions initially assumed to be inconsequential.
This study also serves as a platform for assessing results of RNA structural and stability studies. Here, a systematic analysis and comparison of mRNA MFE prediction tools was completed using 3 genes, 5 prediction tools and 10 RNA fragment lengths, revealing that these tools exhibit a similar linear regression profile across the assessed mRNA fragment sizes. In spite of these tools being developed independently and carrying slight parameter variances, the software used in this study show a high level of agreement in terms of their final MFE determination. Based on utilization of these tools in the assessment of mutation data sets, we have found no qualitative superiority among these five software programs. In considering the feasibility of calculations, which favours smaller fragment lengths, and achieving the highest possible biological correlation (the effect and type of the mutation), we conclude that 101-151 nucleotides is the most realistic mRNA fragment size range for MFE prediction and, thus, may serve as a plausible starting point for future assessment of point mutations. It is imperative that studies using such tools specify the prediction tool, nucleotide segment length and other relevant settings to allow for subsequent meta-analysis.
Conclusions
In this study, we find that disease-associated mutations tend to occur in more thermodynamically stable regions of mRNA in F8 and DMD, which points to an unappreciated role for mRNA structure in determining pathogenicity of point mutations. This may suggest that interchanging codons or introducing mutations in less stable mRNA regions could be less likely to result in deleterious effects on protein expression or function. Undoubtedly, thermodynamic stability of mRNA is not the sole factor that determines the harmfulness of a given mutation. But our observations suggest that additional information may lie beyond the amino acid level. With the expanding role of bioengineered recombinant protein therapeutics, there may be merit to evaluating mutations included in the expression sequence at both the protein and RNA level. More broadly, this study encourages the continued use of RNA prediction tools to assess uncharacterized synonymous and non-synonymous mutations.
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